Global Infectious Disease Diagnostics Market Size, Share, Growth Analysis Report - Forecast 2034

Infectious Disease Diagnostics Market: Industry Perspective

The global infectious disease diagnostics market size was worth around USD 22.86 Billion in 2024 and is predicted to grow to around USD 46.06 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 7.4% between 2025 and 2034. The report analyzes the global infectious disease diagnostics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the infectious disease diagnostics industry.

Request Free Sample

Infectious Disease Diagnostics Market: Overview

Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens, and molecular methods. Diagnostic tests are crucial for diagnosing diseases and for the overall improvement of global health. Traditional methods were time-consuming and often produced inaccurate results. This led to the emergence of quick, accurate, and portable testing products in the market.

The growth of the infectious disease diagnosis market is mainly due to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, Swine Flu, etc.; growing awareness for early detection using specific diagnostic tests; progress in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized testing services.

Key Insights

• As per the analysis shared by our research analyst, the global infectious disease diagnostics market is estimated to grow annually at a CAGR of around 7.4% over the forecast period (2025-2034).
• Regarding revenue, the global infectious disease diagnostics market size was valued at around USD 22.86 Billion in 2024 and is projected to reach USD 46.06 Billion by 2034.
• The infectious disease diagnostics market is projected to grow at a significant rate due to rising prevalence of infectious diseases, increasing demand for rapid and accurate diagnostic tools, and advancements in molecular diagnostics and point-of-care testing.
• Based on Product, the Reagents segment is expected to lead the global market.
• On the basis of Type of Testing, the Laboratory Testing segment is growing at a high rate and will continue to dominate the global market.
• Based on the Technology, the Immunodiagnostics segment is projected to swipe the largest market share.
• By Disease Type, the COVID-19 segment is expected to dominate the global market.
• In terms of End-User, the Diagnostic Laboratories segment is anticipated to command the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Infectious Disease Diagnostics Market: Growth Drivers

The global prevalence of infectious diseases and onset of COVID-19

The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.

Infectious disease is a type of disease caused by different microorganisms present in the surroundings. Infectious disease diagnostics includes different techniques, instruments, and consumables to diagnose the presence of microorganisms in the human body. The lack of sanitation and unhygienic conditions in the developing and under developing regions are the main causes for the increased prevalence of infectious disease. Due to the constant increase in the infectious diseases, most of the companies anticipate focusing on the development of in vitro diagnostics in the forecast period. Most of the infections are spread from bacteria and viruses. Bacterial infections and sexually transmitted diseases are the most common infections among others.

Infectious Disease Diagnostics Market: Restraints

Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario

In underdeveloped and low-income regions, lack of training among clinicians and poor accessibility has led to decreased adoption of Infectious Disease Diagnostics test kits. Moreover, Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

One of the major factors driving the growth of infectious disease diagnostics market over the forecast period is the increased prevalence of infectious disease. As per the UNAIDS report, there were around 36.7 million people in the world diagnosed with HIV/AIDS at the end of 2016 out of these, 2.1 million were children below 15 years of age. Increasing rate of infectious diseases has led to the increased adoption of molecular diagnostics over the forecast period. Moreover, increase in the government initiatives to prevent infectious disease and awareness programs are expected to promote the growth of infectious disease diagnostics market.

Furthermore, market players are involved in the development of new and advanced technologies for the diagnosis of various infectious diseases at an early stage to provide better treatment. All the above factors are expected to support the growth of infectious disease diagnostics market over the forecast period. However, lack of awareness about advanced technologies and poor laboratory conditions are the major factors expected to inhibit the growth of infectious disease diagnostics market in the near future.

Infectious Disease Diagnostics Market: Segmentation Analysis

The global infectious disease diagnostics market is segmented based on Product, Type of Testing, Technology, Disease Type, End-User, and region.

Based on Product, the global infectious disease diagnostics market is divided into Reagents, Kits, and Consumables, Instruments, and Software & Services.

On the basis of Type of Testing, the global infectious disease diagnostics market is bifurcated into Laboratory Testing, and POC Testing.

By Technology, the global infectious disease diagnostics market is split into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies.

In terms of Disease Type, the global infectious disease diagnostics market is categorized into COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases.

By End-User, the global Infectious Disease Diagnostics market is divided into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users.

Infectious Disease Diagnostics Market: Report Scope

Recent Developments

• In May 2021, Torus Biosystems revealed the USD 25 million series-A financing to advance infectious disease diagnostics across healthcare settings.
• In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Infectious Disease Diagnostics Market: Regional Landscape

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028, owing to an increase in the prevalence of infectious diseases, a rise in demand for early diagnosis, development of healthcare infrastructure, technological advancement in diagnostic testing, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Infectious Disease Diagnostics Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the infectious disease diagnostics market on a global and regional basis.

The global infectious disease diagnostics market is dominated by players like:

• Abbott Laboratories (US)
• F. Hoffmann-La Roche Ltd(Switzerland)
• bioMérieux SA (France)
• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Quidel Corporation(US)
• Hologic Inc (US)
• Siemens Healthineers AG (Germany)
• Becton
• Dickinson and Company (US)
• PerkinElmer Inc. (US)
• QIAGEN (Netherlands)
• Grifols S.A. (Spain)
• DiaSorin S.p.A (Italy)
• Bio-Rad Laboratories Inc (US)
• Sysmex Corporation (Japan)
• Ortho Clinical Diagnostics (US)
• Luminex Corporation (US)
• Meridian Bioscience (US)
• Genetic Signatures (Australia)
• OraSure Technologies (US)
• Trinity Biotech Plc. (Ireland)
• Chembio Diagnostic Systems Inc (US)
• Seegene Inc. (South Korea)
• Co-Diagnostics Inc (US)
• ELITechGroup (France)
• Epitope Diagnostics Inc (US)
• Trivitron Healthcare (India)
• Meril Life Sciences Pvt. Ltd. (India)
• InBios International Inc (US)
• and ABACUS Diagnostica Oy (Finland)

The global infectious disease diagnostics market is segmented as follows;

By Product

• Reagents
• Kits
• and Consumables
• Instruments
• and Software & Services

By Type of Testing

• Laboratory Testing
• and POC Testing

By Technology

• Immunodiagnostics
• Clinical Microbiology
• PCR
• INAAT
• DNA Sequencing & NGS
• DNA Microarrays
• and Other Technologies

By Disease Type

• COVID-19
• HIV
• HAIs
• Hepatitis
• CT/NG
• HPV
• TB
• Influenza
• and Other Infectious Diseases

By End-User

• Diagnostic Laboratories
• Hospitals & Clinics
• Academic Research Institutes
• and Other End Users

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America